Global Medical REIT (NYSE: GMRE) is one of 23 publicly-traded companies in the “Healthcare REITs” industry, but how does it compare to its peers? We will compare Global Medical REIT to related companies based on the strength of its profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.
Global Medical REIT pays an annual dividend of $0.80 per share and has a dividend yield of 9.7%. Global Medical REIT pays out -400.0% of its earnings in the form of a dividend. As a group, “Healthcare REITs” companies pay a dividend yield of 5.6% and pay out 145.9% of their earnings in the form of a dividend. Global Medical REIT is clearly a better dividend stock than its peers, given its higher yield and lower payout ratio.
Global Medical REIT has a beta of -48.01, suggesting that its share price is 4,901% less volatile than the S&P 500. Comparatively, Global Medical REIT’s peers have a beta of -2.80, suggesting that their average share price is 380% less volatile than the S&P 500.
Insider & Institutional Ownership
41.0% of Global Medical REIT shares are owned by institutional investors. Comparatively, 82.7% of shares of all “Healthcare REITs” companies are owned by institutional investors. 16.5% of Global Medical REIT shares are owned by company insiders. Comparatively, 6.2% of shares of all “Healthcare REITs” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
This table compares Global Medical REIT and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Global Medical REIT||-19.98%||-2.86%||-1.39%|
|Global Medical REIT Competitors||35.60%||7.69%||3.77%|
Valuation and Earnings
This table compares Global Medical REIT and its peers revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Global Medical REIT||$8.21 million||-$6.35 million||-41.40|
|Global Medical REIT Competitors||$812.10 million||$208.81 million||74.59|
Global Medical REIT’s peers have higher revenue and earnings than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
This is a breakdown of recent ratings and target prices for Global Medical REIT and its peers, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Global Medical REIT||0||1||5||0||2.83|
|Global Medical REIT Competitors||144||761||683||12||2.35|
Global Medical REIT currently has a consensus target price of $10.75, suggesting a potential upside of 29.83%. As a group, “Healthcare REITs” companies have a potential upside of 31.47%. Given Global Medical REIT’s peers higher possible upside, analysts clearly believe Global Medical REIT has less favorable growth aspects than its peers.
Global Medical REIT peers beat Global Medical REIT on 10 of the 15 factors compared.
Global Medical REIT Company Profile
Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and the leasing of these facilities to clinical operators with market share. The Company’s strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market operators under long-term triple-net leases.
What are top analysts saying about Global Medical REIT? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Global Medical REIT and related companies.